In Alzheimer's disease Memancad D Tablet improves learning, memory and information processing (cognitive function) in people with mild to moderate Alzheimer's disease. These problems in memory and thinking may start interfering with daily activities and worsen your condition. This medicine will help in managing Alzheimer’s disease effectively. It will make it easier for you to carry out your daily activities and improve your quality of life. Do not stop taking it unless advised by the doctor. It can take several weeks for your symptoms to improve; so keep using the medicine even if you do not think it is working.
It is unsafe to consume alcohol with Memancad D Tablet.
Memancad D Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Memancad D Tablet during breastfeeding is not available. Please consult your doctor.
Memancad D Tablet may cause side effects which could affect your ability to drive.
Memancad D Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Memancad D Tablet may not be needed in these patients. Please consult your doctor.
Memancad D Tablet should be used with caution in patients with liver disease. Dose adjustment of Memancad D Tablet may be needed. Please consult your doctor.
If you miss a dose of Memancad D Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Intas Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Eisai Pharmaceuticals India Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Care Formulation Labs Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lifecare Neuro Products Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Crescent Therapeutics Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: La Renon Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Consern Pharma Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sparsh Remedies Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alkem Laboratories Ltd || ₹14.5/tablet (25% cheaper)